Literature DB >> 25660384

Tissue-scale anisotropy and compressibility of tendon in semi-confined compression tests.

Markus Böl1, Alexander E Ehret2, Kay Leichsenring3, Michael Ernst3.   

Abstract

In this study, porcine tendon tissue was tested with a dedicated semi-confined compression set-up that enables us to induce states of either fibrils in compression (mode I), tension (mode II) or at constant length (mode III), respectively. The results suggest that tendon tissue is compressible and demonstrates a significantly stiffer response in mode I than in mode III. This implies that the fibril direction remains the axis of transverse isotropy in compression and that it provides an anisotropic contribution to the tissue stress. These results, which are important for the development of constitutive models for tendon tissue, are discussed with respect to the hierarchical structure of the extracellular matrix.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Keywords:  Compression; Flexor digitorum longus tendon; Tendon tissue; Transverse isotropy

Mesh:

Year:  2015        PMID: 25660384     DOI: 10.1016/j.jbiomech.2015.01.024

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  3 in total

1.  Evaluation of transverse poroelastic mechanics of tendon using osmotic loading and biphasic mixture finite element modeling.

Authors:  Babak N Safa; Ellen T Bloom; Andrea H Lee; Michael H Santare; Dawn M Elliott
Journal:  J Biomech       Date:  2020-06-26       Impact factor: 2.712

2.  Identifiability of tissue material parameters from uniaxial tests using multi-start optimization.

Authors:  Babak N Safa; Michael H Santare; C Ross Ethier; Dawn M Elliott
Journal:  Acta Biomater       Date:  2021-01-11       Impact factor: 8.947

3.  The effect of constitutive representations and structural constituents of ligaments on knee joint mechanics.

Authors:  Gustavo A Orozco; Petri Tanska; Mika E Mononen; Kimmo S Halonen; Rami K Korhonen
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.